Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19.
Salvatore PianoAndrea DalbeniElia VettoreDevis BenfaremoMassimo MattioliCarmine Gabriele GambinoViviana FrambaLorenzo CerrutiAnna MantovaniAndrea MartiniMichele M LuchettiRoberto SerraAnnamaria CattelanRoberto VettorPaolo Angelinull nullPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
LFTs abnormality is common at admission in patients with COVID-19, is associated with systemic inflammation, organ dysfunction and is an independent predictor of transfer to ICU or death.